1. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices 
Ranjit John, MD, Yoshifumi Naka, MD, Soon J. Park, MD, Chittoor Sai-Sudhakar, MD, Christopher Salerno, MD, Kartik S. Sundareswaran, PhD, David J. Farrar, PhD, Carmelo A. Milano, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 147, Issue 2, Pages (February 2014)
DOI: /j.jtcvs
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Patient cohort used in this study. HMII, HeartMate II; BTT, bridge to heart transplant; DT, destination therapy.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Kaplan-Meier survival of patients undergoing HMII alone versus HMII + concurrent valve procedures. HMII, HeartMate II; VP, valve procedure.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

4. Figure 3
Kaplan-Meier survival of patients undergoing HMII alone and (A) isolated aortic valve procedure (AVP); B, isolated mitral valve procedure (MVP); C, isolated tricuspid valve procedure (TVP); and D, multiple valve procedures. HMII, HeartMate II.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions